PPA
NTGN

Parametric Portfolio Associates’s Neon Therapeutics, Inc. Common Stock NTGN Stock Holding History

Parametric Portfolio Associates’s Portfolio NTGN Stock Details NTGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-37,408
Closed -$177K – 4039
2019
Q2 		$177K Sell
37,408
-2,093
-5% -$11.7K ﹤0.01% 3761
2019
Q1 		$255K Sell
39,501
-13,426
-25% -$70.3K ﹤0.01% 3623
2018
Q4 		$266K Buy
52,927
+20,093
+61% +$141K ﹤0.01% 3563
2018
Q3 		$280K Buy
32,834
+6,834
+26% +$75.7K ﹤0.01% 3636
2018
Q2 		$328K Buy
+26,000
New +$356K ﹤0.01% 3521

Other funds holding NTGN

TGI
TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HMC
Harvard Management Company Boston, Massachusetts $4.26B AUM 5.81% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $203M AUM 34.78% 1-Year Est. Return
ECM
Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Parametric Portfolio Associates's NTGN Position: Q3 2019 in Review

Parametric Portfolio Associates sold out of Neon Therapeutics, Inc. Common Stock (NTGN) in Q3 2019, closing a stake of 37,408 shares — an estimated $177K sold.

Parametric Portfolio Associates first reported a position in NTGN in Q2 2018 and held it in 5 quarters. The position peaked at $328K in Q2 2018. 58 funds tracked by Wall St. Rank hold NTGN as of Q3 2019.

  • Parametric Portfolio Associates reported no remaining Neon Therapeutics, Inc. Common Stock position as of Q3 2019 after selling out during the quarter.
  • Parametric Portfolio Associates sold 37,408 Neon Therapeutics, Inc. Common Stock shares in Q3 2019, an estimated $177K.
  • Parametric Portfolio Associates first reported a position in Neon Therapeutics, Inc. Common Stock in Q2 2018 and held it in 5 quarters.
  • Parametric Portfolio Associates's Neon Therapeutics, Inc. Common Stock position peaked at $328K in Q2 2018.
  • 58 funds tracked by Wall St. Rank held Neon Therapeutics, Inc. Common Stock as of Q3 2019.

Based on Parametric Portfolio Associates's 13F filing for Q3 2019, filed 15 Nov 2019.